MEDICURE INC. MCUJF news, videos and press releases
For more news please use our advanced search feature.
MEDICURE INC. MCUJF - More news...
MEDICURE INC. MCUJF - More news...
- Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy
- Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results
- Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024
- Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024
- Medicure Announces Further Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of West Olympia Pharmacy
- Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy
- Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Pharmacy
- Medicure Reports Financial Results For Quarter Ended September 30, 2024
- Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member
- Medicure Announces Positive Settlement of Product Development and Supply Contracts
- Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property
- Medicure Reports Financial Results for Quarter Ended June 30, 2024
- Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
- Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results
- Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
- Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
- Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023
- Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes
- Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease
- Medicure Reports Financial Results for Quarter Ended September 30, 2023
- Medicure Reiterates its Commitment to Providing Exceptional Access to its Branded Pitavastatin (Zypitamag) to People Living With HIV
- Medicure Reports Financial Results For Quarter Ended June 30, 2023
- Medicure to Present Financial Results on July 31, 2023 Call at 8:30 AM ET for Quarter Ended June 30, 2023
- Medicure Reports Financial Results for Quarter Ended March 31, 2023
- Medicure Reports Financial Results for Quarter and Year Ended December 31, 2022
- Medicure To Present Financial Results on April 10, 2023 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2022
- Medicure Reports Financial Results for Quarter Ended September 30, 2019
- Medicure Q3 2019 Results and Conference Call Dates
- Medicure Announces Commencement of Substantial Issuer Bid
- Medicure Announces Intention to Commence Substantial Issuer Bid
